A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Large-scale Production of Recombinant RNAs on a Circular Scaffold Using a Viroid-derived System in Escherichia coli

8.9K views

⸱

DOI:

10.3791/58472

⸱

November 30th, 2018

 ,  , 

In This Article

Summary

Here, we present a protocol to produce large amounts of recombinant RNA in Escherichia coli by co-expressing a chimeric RNA that contains the RNA of interest in a viroid scaffold and a plant tRNA ligase. The main product is a circular molecule that facilitates purification to homogeneity.

Abstract

With increasing interest in RNA biology and the use of RNA molecules in sophisticated biotechnological applications, the methods to produce large amounts of recombinant RNAs are limited. Here, we describe a protocol to produce large amounts of recombinant RNA in Escherichia coli based on co-expression of a chimeric molecule that contains the RNA of interest in a viroid scaffold and a plant tRNA ligase. Viroids are relatively small, non-coding, highly base-paired circular RNAs that are infectious to higher plants. The host plant tRNA ligase is an enzyme recruited by viroids that belong to the family Avsunviroidae, such as Eggplant latent viroid (ELVd), to mediate RNA circularization during viroid replication. Although ELVd does not replicate in E. coli, an ELVd precursor is efficiently transcribed by the E. coli RNA polymerase and processed by the embedded hammerhead ribozymes in bacterial cells, and the resulting monomers are circularized by the co-expressed tRNA ligase reaching a remarkable concentration. The insertion of an RNA of interest into the ELVd scaffold enables the production of tens of milligrams of the recombinant RNA per liter of bacterial culture in regular laboratory conditions. A main fraction of the RNA product is circular, a feature that facilitates the purification of the recombinant RNA to virtual homogeneity. In this protocol, a complementary DNA (cDNA) corresponding to the RNA of interest is inserted in a particular position of the ELVd cDNA in an expression plasmid that is used, along the plasmid to co-express eggplant tRNA ligase, to transform E. coli. Co-expression of both molecules under the control of strong constitutive promoters leads to production of large amounts of the recombinant RNA. The recombinant RNA can be extracted from the bacterial cells and separated from the bulk of bacterial RNAs taking advantage of its circularity.

Introduction

In contrast to DNA and proteins, protocols for easy, efficient and cost-effective production of large amounts of RNA are not abundant. However, research and industry demand increasing amounts of these biomolecules to investigate their unique biological properties1, or to be employed in sophisticated biotechnological applications, including their use as highly specific aptamers2, therapeutic agents3, or selective pesticides4. In vitro transcription and chemical synthesis are commonly used in research to produce RNA. However, these methods entail important limitations when la....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Plasmid Construction

  1. Amplify by PCR (or by reverse transcription PCR if starting from an RNA template) the cDNA corresponding to the RNA of interest using primers with 5’ extension to allow assembly into the expression plasmid. To avoid undesired mutations, use a high-fidelity DNA polymerase.
    1. To insert the cDNA in the expression plasmid by Gibson assembly20, add the following 5’ extensions to the PCR primers: forward, 5’-tctccccctcccaggtactatccccttXXXXXXXXXXXXXXXXXXXXXX-3’; reverse, 5’-ccctcctagggaacacatccttgaXXXXXXXXXXXXXXXXXXXXXX-3’; X represents nucleotides ....

Access restricted. Please log in or start a trial to view this content.

Results

To produce recombinant RNA in E. coli using the ELVd-derived system12, the RNA of interest is grafted into an ELVd RNA scaffold. This chimeric RNA is co-expressed along the eggplant tRNA ligase in E. coli. Once processed, cleaved and circularized, the chimeric circular RNA, from which the RNA of interest protrudes, likely forms a ribonucleoprotein complex with the co-expressed eggplant enzyme that reaches remarkable concentration in the bacterial .......

Access restricted. Please log in or start a trial to view this content.

Discussion

While researching the ELVd sequence and structure requirements involved in the recognition by the eggplant tRNA ligase, we noticed that co-expression of both molecules in the non-host E. coli led to an unexpected large accumulation of viroid circular forms in bacterial cells19. We understood that the large accumulation of viroid RNA in E. coli most probably was the consequence of co-expressing a highly stable RNA molecule, such as the relatively small (333 nt), highly based-paire.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that the technology described in this protocol has been patented (US Patent No. EP14382177.5, PCT/EP2015/060912).

Acknowledgements

This work was supported by grants BIO2017-83184-R and BIO2017-91865-EXP from the Spanish Ministerio de Ciencia, Innovación y Universidades (co-financed FEDER funds).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Phusion High-Fidelity DNA polymeraseThermo ScientificF530S
Bpi IThermo ScientificER1011
AgaroseConda8010D1 low EEO
TrisPanReac AppliChemA1086,1000
Acetic acidPanReac AppliChem131008.1214
EDTASigma-AldrichE5134-500G
Ethidium bromidePanReac AppliChemA1152,00251%
Zymoclean Gel DNA RecoveryZymo ResearchD4001
NanoDropThermoFisher ScientificND-3300
NEBuilder HiFi DNA Assembly Master MixNew England BioLabsE2621S
DNA Clean & ConcentratorZymo ResearchD4003
EporatorEppendorf4309000019
Escherichia coli DH5αInvitrogen18265-017
TryptoneIntron BiotechnologyBa2014
Yeast extractIntron Biotechnology48045
NaClPanReac AppliChem131659.1211
AgarIntron Biotechnology25999
AmpicillinPanReac AppliChemA0839,0010
X-galDuchefaX1402.1000
N,N-DimethylformamidePanReac AppliChem131785.1611
NucloSpin PlasmidMacherey-Nagel22740588.250
Escherichia coli BL21(DE3)Novagen69387-3
Escherichia coli HT115(DE3)Ref. Timmons et al., 2001
ChloramphenicolDuchefaC 0113.0025
GlycerolPanReac AppliChem122329.121187%
KH2PO4PanReac AppliChem131509.1210
K2HPO4PanReac AppliChem122333.1211
HClPanReac AppliChem131020.1211
PhenolScharlauFE0479100090%
ChloroformPanReac AppliChemA3691,1000
Filtropur S 0.2Sarstedt83.1826.001
HiTrap DEAE Sepharose FF columnGE Healthcare Life Sciences17-5055-01
ÄKTAprime plus liquid chromatography systemGE Healthcare Life Sciences11001313
AcrylamydePanReac AppliChemA1089,10002K
N,N’-methylenebisacrylamideSigma-AldrichM7279-100G
UreaPanReac AppliChem146392.1211
Boric acidPanReac AppliChemA2940,1000
FormamidePanReac AppliChemA0937,2500
Bromophenol blueSigma-AldrichB8026-5G
Xylene cyanolSigma-AldrichX4126-10G
N,N′-Bis(acryloyl)cystamineSigma-AldrichA4929-5G

References

  1. Wang, J., et al. Current Research on Non-Coding Ribonucleic Acid (RNA). Genes. 8 (12), (2017).
  2. Hamada, M. In silico approaches to RNA aptamer design. Biochimie. 145, 8-14 (2018).
  3. Bobbin, M. L., Rossi, J. J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Recombinant RNA ProductionEscherichia coli ExpressionViroid Scaffold SystemCircular RNA PurificationtRNA Ligase Co-expressionPlasmid ConstructionGel ElectrophoresisChromatography PurificationTwo-Dimensional PAGEAnion Exchange Chromatography